108 related articles for article (PubMed ID: 16188993)
1. Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.
Simsek E; Mehta A; Zhou T; Dwek RA; Block T
J Virol; 2005 Oct; 79(20):12914-20. PubMed ID: 16188993
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum.
Lu X; Lu Y; Geschwindt R; Dwek RA; Block TM
DNA Cell Biol; 2001 Oct; 20(10):647-56. PubMed ID: 11749723
[TBL] [Abstract][Full Text] [Related]
3. ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins.
Zhang J; Zheng T; Zhou X; Wang H; Li Z; Huan C; Zheng B; Zhang W
Virol Sin; 2021 Aug; 36(4):678-691. PubMed ID: 33534085
[TBL] [Abstract][Full Text] [Related]
4. Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.
Norton PA; Menne S; Sinnathamby G; Betesh L; Cote PJ; Philip R; Mehta AS; Tennant BC; Block TM
Hepatology; 2010 Oct; 52(4):1242-50. PubMed ID: 20658465
[TBL] [Abstract][Full Text] [Related]
5. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors.
Fujita K; Omura S; Silver J
J Gen Virol; 1997 Mar; 78 ( Pt 3)():619-25. PubMed ID: 9049413
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
7. Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase.
Wang Y; Androlewicz MJ
Biochem Biophys Res Commun; 2000 Apr; 271(1):22-7. PubMed ID: 10777675
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner.
Li YX; Ren YL; Fu HJ; Zou L; Yang Y; Chen Z
PLoS One; 2016; 11(7):e0159089. PubMed ID: 27434097
[TBL] [Abstract][Full Text] [Related]
9. alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
Simsek E; Lu X; Ouzounov S; Block TM; Mehta AS
Antivir Chem Chemother; 2006; 17(5):259-67. PubMed ID: 17176630
[TBL] [Abstract][Full Text] [Related]
10. Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway.
Sheu SY; Lo SJ
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3031-9. PubMed ID: 7964612
[TBL] [Abstract][Full Text] [Related]
11. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
12. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.
Chua PK; Wang RY; Lin MH; Masuda T; Suk FM; Shih C
J Virol; 2005 Nov; 79(21):13483-96. PubMed ID: 16227269
[TBL] [Abstract][Full Text] [Related]
13. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited.
Lu X; Mehta A; Dadmarz M; Dwek R; Blumberg BS; Block TM
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2380-5. PubMed ID: 9122203
[TBL] [Abstract][Full Text] [Related]
14. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation.
Qiu W; Kohen-Avramoglu R; Mhapsekar S; Tsai J; Austin RC; Adeli K
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):571-7. PubMed ID: 15618547
[TBL] [Abstract][Full Text] [Related]
15. Mannosidase action, independent of glucose trimming, is essential for proteasome-mediated degradation of unassembled glycosylated Ig light chains.
Chillarón J; Adán C; Haas IG
Biol Chem; 2000 Dec; 381(12):1155-64. PubMed ID: 11209750
[TBL] [Abstract][Full Text] [Related]
16. [Study on the relations between hepatitis B virus large surface protein (LHBs) and HBV YMDD mutation].
Wang LJ; Sun Y; Fu HP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):48-9. PubMed ID: 20848850
[TBL] [Abstract][Full Text] [Related]
17. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice.
Geissler M; Schirmbeck R; Reimann J; Blum HE; Wands JR
Hepatology; 1998 Jul; 28(1):202-10. PubMed ID: 9657113
[TBL] [Abstract][Full Text] [Related]
18. Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker.
Norton PA; Conyers B; Gong Q; Steel LF; Block TM; Mehta AS
J Virol Methods; 2005 Mar; 124(1-2):167-72. PubMed ID: 15664065
[TBL] [Abstract][Full Text] [Related]
19. [Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome].
Xu W; Lin FQ; Liu JF; Fu LF; Hong WS; Zhou MN; Xu AE; Guan CP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):123-7. PubMed ID: 23648349
[TBL] [Abstract][Full Text] [Related]
20. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
